- Home
- NAUT
as 04-18-2025 12:40pm EST
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 188.3M | IPO Year: | N/A |
| Target Price: | $3.58 | AVG Volume (30 days): | 174.6K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $3.09 | Next Earning Date: | 04-29-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Nautilus Biotechnolgy Inc. (NAUT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Patel Sujal M | NAUT | CEO, President, and Secretary | Mar 19 '25 | Buy | $1.00 | 77,233 | $76,918.09 | 10,117,788 |
Latest Nautilus Biotechnolgy Inc. News
NAUT Breaking Stock News: Dive into NAUT Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
Simply Wall St.
19 days ago
We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate
GuruFocus.com
2 months ago
Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ...
GlobeNewswire
2 months ago
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Simply Wall St.
2 months ago
Blade Air Mobility Leads The Charge Among 3 US Penny Stocks
GlobeNewswire
2 months ago
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
GlobeNewswire
2 months ago
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Simply Wall St.
2 months ago
One Nautilus Biotechnology Insider Raised Their Stake In The Previous Year
Compare NAUT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NAUT Nautilus Biotechnolgy Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.